search
Back to results

Wireless Spinal Cord Stimulation for Chronic Pain

Primary Purpose

Back Pain

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Freedom SCS System
Sponsored by
Stimwave Technologies
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Back Pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Subject is ≥ 18 years of age at time of informed consent;
  • Subjects have been diagnosed with chronic back or back and leg pain with an average VAS > 5 (on a 10 scale) over the course of the last month for back pain based on baseline pain diary;
  • Subject diagnosis with chronic back or back and leg pain associated with FBSS refractory to conventional medical management for at least 12 months prior to enrollment;
  • Based on the medical opinion of the Principal Investigator, subject has a stable pain medication regiment;
  • Based on the medical opinion of the Principal Investigator, there is no evidence of anatomic abnormalities that could jeopardize the placement of the device or pose a hazard to the subject;
  • Based on the opinion of the Principal Investigator, subject is willing and able to operate the patient programmer, recharging equipment, diary and has the ability to undergo study assessments and provide accurate responses;
  • Based on the opinion of the implanter, subject is a good surgical subject for the implant procedure;
  • Subject is willing to undergo surgical implant procedure, attend visits as scheduled, and comply with the study requirements;
  • Subject is male or non-pregnant female;
  • Subject is deemed to be neuro-psycho-socially appropriate for implantation therapies based of the assessment of a Clinical Psychologist, using face-to-face encounters and the psychological testing described in the measures;
  • Subject is capable of giving informed consent;
  • Subject lives within reasonable distance from the study site (circumference of 50 miles).

Exclusion Criteria:

  • Obvious mechanical instability related to pain (diagnosed by imaging taken within the past 6 months);
  • Unresolved Malignancies in last six months;
  • Subject has post-herpetic neuralgia (shingles);
  • Subject has an active systemic infection or is immune-compromised;
  • Based on the medical opinion of the Principal Investigator, Psychologist and/or Psychiatrist, the subject has other psychological conditions (e.g., psychosis, suicidal ideation, borderline personality disorder, somatization, narcissism), other health conditions (e.g., substance abuse, another chronic condition requiring the regular use of opioid medication), or other legal concerns that would preclude his/her enrollment in the study or potentially confound the results of the study;
  • Subject is currently enrolled in or plans to enroll in any concurrent drug and/or device study while participating in this study;
  • Insulin-dependent diabetic who is not controlled through diet and/or medication (determined by the physician) or non-insulin dependent diabetic who is not well controlled through diet and/or medication;
  • Bleeding complications or coagulopathy issues;
  • Pregnant/lactating or not using adequate birth control;
  • A life expectancy of less than one year;
  • Any active implanted device whether turned off or on;
  • A previous SCS experience;
  • Conditions requiring Magnetic Resonance Imaging (MRI) evaluation or diathermy procedures.

Sites / Locations

  • Nuvo Spine and Sports Institute & Ortho Regenerative Center
  • USC Spine Center, Keck Hospital of USC
  • Compass Research
  • Anesthesia Pain Care Consultants
  • The Center for Clinical Research
  • Cleveland Clinic
  • Precision Spine Care

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Freedom SCS System - 1500 HZ

Arm Description

Epidural Space covering vertebrae level T8-T11 determined by paresthesia mapping for painful area.

Outcomes

Primary Outcome Measures

Pain Score
A 50% reduction in VAS scores when compared to baseline.

Secondary Outcome Measures

Percentage change in VAS Back from baseline
The percentage reduction in VAS back pain
Percentage change in VAS Leg from baseline
The percentage reduction in VAS leg pain
Oswestry Disability Index (ODI) Score
The change from baseline in functionality using the ODI
Patient Satisfaction
The change in satisfaction as measured by Patient Global Impression of Change
Disability Score
The change in European Quality of Life 5 Dimension
Sleep Quality
Frequency of sleep disturbances reported from diary
Procedure time
The time measured to implant the device from operative notes
Opioid Reduction
The reduction in opioids as reported by patient prescription
Adverse Events
The incidence of device related adverse events

Full Information

First Posted
July 31, 2015
Last Updated
October 5, 2021
Sponsor
Stimwave Technologies
Collaborators
The Cleveland Clinic, The Center for Clinical Research, Winston-Salem, NC, Anesthesia Pain Care Consultants, Tamarac, FL, USA, Precision Spine Care, Tyler, TX, USA, Nuvo Spine and Sports Institute & Ortho Regenerative Center, Encino, CA, USA, Compass Research LLC, Orlando, FL, USA, USC Spine, Keck hospital of USC, Los Angeles, CA, USA
search

1. Study Identification

Unique Protocol Identification Number
NCT02514590
Brief Title
Wireless Spinal Cord Stimulation for Chronic Pain
Official Title
Multi-center, Prospective, Clinical Trial of Wireless Spinal Cord Stimulation in the Treatment of Chronic Pain
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
July 2016 (Actual)
Primary Completion Date
January 2019 (Actual)
Study Completion Date
July 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Stimwave Technologies
Collaborators
The Cleveland Clinic, The Center for Clinical Research, Winston-Salem, NC, Anesthesia Pain Care Consultants, Tamarac, FL, USA, Precision Spine Care, Tyler, TX, USA, Nuvo Spine and Sports Institute & Ortho Regenerative Center, Encino, CA, USA, Compass Research LLC, Orlando, FL, USA, USC Spine, Keck hospital of USC, Los Angeles, CA, USA

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to assess the effectiveness of the Stimwave Spinal Cord Stimulator (SCS) System for treatment of chronic pain
Detailed Description
This is a multi-center, prospective study in which subjects will receive a Freedom SCS System and to receive stimulation at a frequency between 5 Hz to 1500 Hz . Enrollment will continue until 49 subjects have been implanted. Subjects will have chronic back or back and leg pain refractory to standard medical treatment associated with Failed Back Surgery Syndrome (FBSS). Subjects will be followed for a 6-month period after a maximum one-month trial period. At the end of 6 months follow-up, all subjects will assess the outcomes of their appointed therapy and continue with long-term use of the system. Stimulators will be placed at the following sites to target the painful area: • Epidural Space midline covering vertebrae levels T8 through T11 (one stimulator placed at the top of T8 and the second stimulator placed at the middle of T9). Paresthesia mapping will be utilised to determine the optimal location for stimulation of the painful area.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Back Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
49 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Freedom SCS System - 1500 HZ
Arm Type
Experimental
Arm Description
Epidural Space covering vertebrae level T8-T11 determined by paresthesia mapping for painful area.
Intervention Type
Device
Intervention Name(s)
Freedom SCS System
Intervention Description
This Freedom SCS System is based on wireless neuromodulation technology. This technology includes octapolar stimulators with embedded receivers. The energy source is a small, external, rechargeable transmitter, which is worn by the subject. The device is programmed to have a 5-1500 Hz therapy.
Primary Outcome Measure Information:
Title
Pain Score
Description
A 50% reduction in VAS scores when compared to baseline.
Time Frame
6 Months
Secondary Outcome Measure Information:
Title
Percentage change in VAS Back from baseline
Description
The percentage reduction in VAS back pain
Time Frame
6 Months
Title
Percentage change in VAS Leg from baseline
Description
The percentage reduction in VAS leg pain
Time Frame
6 Months
Title
Oswestry Disability Index (ODI) Score
Description
The change from baseline in functionality using the ODI
Time Frame
6 Months
Title
Patient Satisfaction
Description
The change in satisfaction as measured by Patient Global Impression of Change
Time Frame
6 Months
Title
Disability Score
Description
The change in European Quality of Life 5 Dimension
Time Frame
6 Months
Title
Sleep Quality
Description
Frequency of sleep disturbances reported from diary
Time Frame
6 Months
Title
Procedure time
Description
The time measured to implant the device from operative notes
Time Frame
7 Days post implant
Title
Opioid Reduction
Description
The reduction in opioids as reported by patient prescription
Time Frame
6 Months
Title
Adverse Events
Description
The incidence of device related adverse events
Time Frame
6 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subject is ≥ 18 years of age at time of informed consent; Subjects have been diagnosed with chronic back or back and leg pain with an average VAS > 5 (on a 10 scale) over the course of the last month for back pain based on baseline pain diary; Subject diagnosis with chronic back or back and leg pain associated with FBSS refractory to conventional medical management for at least 12 months prior to enrollment; Based on the medical opinion of the Principal Investigator, subject has a stable pain medication regiment; Based on the medical opinion of the Principal Investigator, there is no evidence of anatomic abnormalities that could jeopardize the placement of the device or pose a hazard to the subject; Based on the opinion of the Principal Investigator, subject is willing and able to operate the patient programmer, recharging equipment, diary and has the ability to undergo study assessments and provide accurate responses; Based on the opinion of the implanter, subject is a good surgical subject for the implant procedure; Subject is willing to undergo surgical implant procedure, attend visits as scheduled, and comply with the study requirements; Subject is male or non-pregnant female; Subject is deemed to be neuro-psycho-socially appropriate for implantation therapies based of the assessment of a Clinical Psychologist, using face-to-face encounters and the psychological testing described in the measures; Subject is capable of giving informed consent; Subject lives within reasonable distance from the study site (circumference of 50 miles). Exclusion Criteria: Obvious mechanical instability related to pain (diagnosed by imaging taken within the past 6 months); Unresolved Malignancies in last six months; Subject has post-herpetic neuralgia (shingles); Subject has an active systemic infection or is immune-compromised; Based on the medical opinion of the Principal Investigator, Psychologist and/or Psychiatrist, the subject has other psychological conditions (e.g., psychosis, suicidal ideation, borderline personality disorder, somatization, narcissism), other health conditions (e.g., substance abuse, another chronic condition requiring the regular use of opioid medication), or other legal concerns that would preclude his/her enrollment in the study or potentially confound the results of the study; Subject is currently enrolled in or plans to enroll in any concurrent drug and/or device study while participating in this study; Insulin-dependent diabetic who is not controlled through diet and/or medication (determined by the physician) or non-insulin dependent diabetic who is not well controlled through diet and/or medication; Bleeding complications or coagulopathy issues; Pregnant/lactating or not using adequate birth control; A life expectancy of less than one year; Any active implanted device whether turned off or on; A previous SCS experience; Conditions requiring Magnetic Resonance Imaging (MRI) evaluation or diathermy procedures.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nagy Mekhail
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nuvo Spine and Sports Institute & Ortho Regenerative Center
City
Beverly Hills
State/Province
California
ZIP/Postal Code
90212
Country
United States
Facility Name
USC Spine Center, Keck Hospital of USC
City
Los Angeles
State/Province
California
ZIP/Postal Code
90033
Country
United States
Facility Name
Compass Research
City
Orlando
State/Province
Florida
ZIP/Postal Code
32806
Country
United States
Facility Name
Anesthesia Pain Care Consultants
City
Tamarac
State/Province
Florida
ZIP/Postal Code
33301
Country
United States
Facility Name
The Center for Clinical Research
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27103
Country
United States
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
Facility Name
Precision Spine Care
City
Tyler
State/Province
Texas
ZIP/Postal Code
75701
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Wireless Spinal Cord Stimulation for Chronic Pain

We'll reach out to this number within 24 hrs